Cellular uptake mechanism and comparative in vitro cytotoxicity studies of monomeric LMWP-siRNA conjugate

被引:18
作者
Ye, Junxiao [1 ,2 ]
Pei, Xing [1 ]
Cui, Hui [1 ]
Yu, Zhili [1 ]
Lee, Hyukjin [3 ]
Wang, Jianxin [4 ]
Wang, Xu [1 ]
Sun, Lu [1 ]
He, Huining [1 ]
Yang, Victor C. [1 ,5 ]
机构
[1] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
[2] Tsinghua Univ, Coll Pharm, Beijing 100084, Peoples R China
[3] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul 13760, South Korea
[4] Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ,Key Lab Smart Drug Delivery, Shanghai, Peoples R China
[5] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Cell penetrating peptide; siRNA delivery; Covalent CPP-siRNA chemical conjugate; Cell uptake mechanism; Cytotoxicity; MOLECULAR-WEIGHT PROTAMINE; PENETRATING PEPTIDES; DRUG-DELIVERY; NANOPARTICLES; VIVO; THERAPEUTICS; COMPLEXES; CELLS; TRANSDUCTION; EFFICIENT;
D O I
10.1016/j.jiec.2018.02.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The covalent attachment of CPPs to siRNA molecules offers great potential for CPP-mediated siRNA delivery. We recently reported a concise and high-yield synthesis strategy of the cell-permeable, cytosol-dissociable LMWP-siRNA covalent conjugate. Herein, cell uptake mechanism and cellular toxicity studies of this conjugate were performed to evaluate the potential of LMWP-siRNA conjugate for clinical translation. Cellular uptake mechanism study indicated that the conjugate could be taken up by cells via multiple pathways, including direct penetration of the plasma membrane and clathrin- and caveolae-independent endocytosis. In vitro cytotoxicity study revealed that the conjugation promoted internalization in a low-toxic fashion. (C) 2018 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 34 条
[1]   The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine [J].
Choi, Young-Suk ;
Lee, Jue Yeon ;
Suh, Jin Sook ;
Kwon, Young-Min ;
Lee, Seung-Jin ;
Chung, Jun-Key ;
Lee, Dong-Soo ;
Yang, Victor C. ;
Chung, Chong-Pyoung ;
Park, Yoon-Jeong .
BIOMATERIALS, 2010, 31 (06) :1429-1443
[2]   Cell-Penetrating Peptides: Design, Synthesis, and Applications [J].
Copolovici, Dana Maria ;
Langel, Kent ;
Eriste, Elo ;
Langel, Ulo .
ACS NANO, 2014, 8 (03) :1972-1994
[3]   Overcoming cellular barriers for RNA therapeutics [J].
Dowdy, Steven F. .
NATURE BIOTECHNOLOGY, 2017, 35 (03) :222-229
[4]   Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections [J].
Draz, Mohamed Shehata ;
Fang, Binbin Amanda ;
Zhang, Pengfei ;
Hu, Zhi ;
Gu, Shenda ;
Weng, Kevin C. ;
Gray, Joe W. ;
Chen, Fanqing Frank .
THERANOSTICS, 2014, 4 (09) :872-892
[5]   Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides:: a comparative study [J].
El-Andaloussi, Samir ;
Jarver, Peter ;
Johansson, Henrik J. ;
Langel, Ulo .
BIOCHEMICAL JOURNAL, 2007, 407 (285-292) :285-292
[6]   Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells [J].
Filion, MC ;
Phillips, NC .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1329 (02) :345-356
[7]   siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model [J].
Freire, Joao Miguel ;
de Figueiredo, Ines Rego ;
Valle, Javier ;
Veiga, Ana Salome ;
Andreu, David ;
Enguita, Francisco J. ;
Castanho, Miguel A. R. B. .
JOURNAL OF CONTROLLED RELEASE, 2017, 245 :127-136
[8]   Poly(ethylenimine) and its role in gene delivery [J].
Godbey, WT ;
Wu, KK ;
Mikos, AG .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :149-160
[9]   Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung [J].
Guenther, Melanie ;
Lipka, Jens ;
Malek, Anastasia ;
Gutsch, Daniela ;
Kreyling, Wolfgang ;
Aigner, Achim .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 77 (03) :438-449
[10]   ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer [J].
Guo, Peng ;
Yang, Jiang ;
Jia, Di ;
Moses, Marsha A. ;
Auguste, Debra T. .
THERANOSTICS, 2016, 6 (01) :1-13